Adenovirus type 4 and type 7 vaccine (Emergent BioSolutions)

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameAdenovirus type 4 and type 7 vaccine (Emergent BioSolutions)

Drug Alias NameAd 4/7 vaccineMPAV Prototype Aadenovirus serotypes 4 and 7 vaccineModernized Production Adenovirus Vaccine - PaxVaxAdenovirus Type 4 and Type 7 Vaccine [A549 Cells] - PaxVax +[6]

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsAdenoviridae Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesEmergent Biosolutions Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesEmergent Biosolutions Inc

Active IndicationsN/A

Inactive IndicationsAdenoviridae Infections

Other Information

ATC CodeN/A